The government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation. It’s an unlikely role for the Food and Drug Administration, a sprawling, century-old bureaucracy that for decades directed most its communications toward doctors and corporations. But FDA Commissioner Dr. Robert Califf has spent the last year warning that growing “distortions and half-truths” surrounding vaccines and other medical products are now “a leading cause of death in America.” “Almost no one should be dying of COVID in the U.S. today,” Califf told The Associated Press, noting the government’s distribution of free vaccines and antiviral medications. “People who are denying themselves that opportunity are dying because they’re misinformed.” Califf, who first led the agency under President Barack Obama, said the FDA could once rely on a few communication channels to reach Americans. “We’re now in a 24/7 sea of information without a user guide for people out there in society,” Califf said. “So this requires us to change the way we communicate.” The FDA’s answer? Short YouTube videos, long Twitter threads and other online postings debunking medical misinformation, including bogus COVID-19 remedies like ivermectin, the anti-parasite drug intended for farm animals. “Hold your horses y’all. Ivermectin may be trending, but it still isn’t authorized or approved to treat COVID-19” the FDA told its 500,000 Twitter followers in April. On Instagram, FDA memes referencing Scooby-Doo and SpongeBob urge Americans to get boosted and ignore misinformation, alongside staid agency postings about the arrival of National Handwashing Awareness Week. The AP asked more than a half-dozen health communication experts about the FDA’s fledgling effort. They said it mostly reflects the latest science on combating misinformation, but they also questioned whether it’s reaching enough people to have an impact — and whether separate FDA controversies are undercutting the agency’s credibility. “The question I start with is, ‘Are you a trusted messenger or not?’” said Dr. Seema Yasmin, a Stanford University professor who studies medical misinformation and trains health officials in responding to it. “In the context of FDA, we can highlight multiple incidents which have damaged the credibility of the agency and deepened distrust of its scientific decisions.” In the last two years the FDA has come under fire for its controversial approval of an unproven Alzheimer’s drug as well as its delayed response to a contaminated baby formula plant, which contributed to a national supply shortage. Meanwhile, the agency’s approach to booster vaccinations has been criticized by some of its top vaccine scientists and advisers. “It’s not fair, but it doesn’t take too many negative stories to unravel the public’s trust,” said Georgetown University’s Leticia Bode, who studies political communication and misinformation. About a quarter of Americans said they have “a lot” of trust in the FDA’s handling of COVID-19, according to a survey conducted last year by University of Pennsylvania researchers, while less than half said they have “some trust.” “The FDA’s word is still one of the most highly regarded pieces of information people want to see,” said Califf, who was confirmed to his second stint leading the FDA last February. As commissioner he is trying to tackle a host of issues, including restructuring the agency’s food safety program and more aggressively deploying FDA scientists to explain vaccine decisions in the […]

The post FDA’s Own Reputation Could be Restraining Its Misinformation Fight appeared first on The Yeshiva World.